wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52937933-21118BC1-F147-404C-85A3-1F0FE7C9C66C
Q52937933-21118BC1-F147-404C-85A3-1F0FE7C9C66C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52937933-21118BC1-F147-404C-85A3-1F0FE7C9C66C
Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma".
P2860
Q52937933-21118BC1-F147-404C-85A3-1F0FE7C9C66C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52937933-21118BC1-F147-404C-85A3-1F0FE7C9C66C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80171df9201998b4f0d611f1bf9900bd71ccf218
P2860
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET